Atlas Trials

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Clinical trial NCT00012363 · COMPLETED

Trial details

NCT number
NCT00012363
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal CancerGastric Cancer
Start date
2001-04-01
Primary completion
2006-04-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.